First Time Loading...

Quest Diagnostics Inc
NYSE:DGX

Watchlist Manager
Quest Diagnostics Inc Logo
Quest Diagnostics Inc
NYSE:DGX
Watchlist
Price: 142.31 USD 1.09%
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

14B
-0.5%
Assets
Growth Rates:
1 Year
+9%
3 Years
+0%
5 Years
+17%
7 Years
+38%
10 Years
+46%
7.5B
-3%
Liabilities
Growth Rates:
1 Year
+12%
3 Years
+5%
5 Years
+13%
7 Years
+37%
10 Years
+35%
6.4B
+2%
Equity
Growth Rates:
1 Year
+6%
3 Years
-5%
5 Years
+22%
7 Years
+39%
10 Years
+61%

Balance Sheet Decomposition
Quest Diagnostics Inc

14B
Assets
7.5B
Liabilities
14B
Assets
7.5B
Liabilities
Current Assets 2.2B
Cash & Short-Term Investments 474m
Receivables 1.3B
Other Current Assets 432m
Non-Current Assets 11.7B
Long-Term Investments 133m
PP&E 2.4B
Intangibles 9B
Other Non-Current Assets 182m
Current Liabilities 2.3B
Accounts Payable 1.2B
Accrued Liabilities 153m
Other Current Liabilities 906m
Non-Current Liabilities 5.2B
Long-Term Debt 3.8B
Other Non-Current Liabilities 1.4B

Balance Sheet
Quest Diagnostics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
192
133
359
137
135
1 192
1 158
872
315
686
Cash Equivalents
192
133
359
137
135
1 192
1 158
872
315
686
Total Receivables
932
901
926
924
1 012
1 063
1 523
1 438
1 195
1 210
Accounts Receivables
932
901
926
924
1 012
1 063
1 520
1 438
1 195
1 210
Other Receivables
0
0
0
0
0
0
3
0
0
0
Inventory
110
84
82
95
99
123
223
208
192
190
Other Current Assets
369
383
164
150
144
112
154
223
196
286
Total Current Assets
1 603
1 501
1 531
1 306
1 390
2 490
3 058
2 741
1 898
2 372
PP&E Net
933
925
1 029
1 145
1 288
1 971
2 231
2 304
2 351
2 418
PP&E Gross
0
925
1 029
1 145
1 288
1 971
2 231
2 304
2 351
2 418
Accumulated Depreciation
0
2 307
2 400
2 526
2 682
2 776
2 992
3 088
3 337
3 416
Intangible Assets
1 071
984
949
1 119
1 207
1 121
1 167
1 167
1 092
1 166
Goodwill
6 032
5 905
6 000
6 335
6 563
6 619
6 873
7 095
7 220
7 733
Long-Term Investments
0
473
443
462
436
482
521
141
132
135
Other Long-Term Assets
218
174
148
136
119
160
176
163
144
198
Other Assets
6 032
5 905
6 000
6 335
6 563
6 619
6 873
7 095
7 220
7 733
Total Assets
9 857
N/A
9 962
+1%
10 100
+1%
10 503
+4%
11 003
+5%
12 843
+17%
14 026
+9%
13 611
-3%
12 837
-6%
14 022
+9%
Liabilities
Accounts Payable
1 191
279
261
224
222
263
446
357
324
1 737
Accrued Liabilities
0
674
647
649
599
730
1 056
1 189
1 034
921
Short-Term Debt
0
0
0
71
98
88
153
116
92
129
Current Portion of Long-Term Debt
518
159
6
36
464
804
2
2
2
303
Other Current Liabilities
0
61
67
77
102
105
119
89
99
84
Total Current Liabilities
1 709
1 173
981
1 057
1 485
1 990
1 776
1 753
1 551
1 815
Long-Term Debt
3 224
3 492
3 728
3 748
3 429
3 966
4 013
4 010
3 978
4 410
Deferred Income Tax
0
0
0
0
0
0
0
0
295
270
Minority Interest
29
99
109
114
128
122
132
118
114
111
Other Liabilities
594
514
654
663
745
1 124
1 346
1 286
1 006
1 109
Total Liabilities
5 556
N/A
5 278
-5%
5 472
+4%
5 582
+2%
5 787
+4%
7 202
+24%
7 267
+1%
7 167
-1%
6 944
-3%
7 715
+11%
Equity
Common Stock
2
2
2
2
2
2
2
2
2
2
Retained Earnings
5 723
6 199
6 613
7 138
7 602
8 174
9 303
7 649
8 290
8 825
Additional Paid In Capital
2 418
2 481
2 545
2 612
2 667
2 722
2 841
2 260
2 295
2 320
Unrealized Security Profit/Loss
0
0
0
0
0
8
8
1
1
1
Treasury Stock
3 815
3 960
4 460
4 783
4 996
5 218
5 366
3 453
4 673
4 826
Other Equity
27
38
72
48
59
47
29
15
22
15
Total Equity
4 301
N/A
4 684
+9%
4 628
-1%
4 921
+6%
5 216
+6%
5 641
+8%
6 759
+20%
6 444
-5%
5 893
-9%
6 307
+7%
Total Liabilities & Equity
9 857
N/A
9 962
+1%
10 100
+1%
10 503
+4%
11 003
+5%
12 843
+17%
14 026
+9%
13 611
-3%
12 837
-6%
14 022
+9%
Shares Outstanding
Common Shares Outstanding
144
143
137
135
135
133
133
119
111
111

See Also

Summary
DGX intrinsic value, competitors valuation, and company profile.
DCF Valuation
DGX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DGX stock valuation using valuation multiples.
Wall Street Estimates
DGX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DGX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.